[
  {
    "ts": null,
    "headline": "Stocks to Watch Friday Recap: Applied Materials, Coinbase, DraftKings",
    "summary": "↗️ Coinbase (COIN): The largest U.S. cryptocurrency exchange swung to a loss in a quarter marked by a selloff in digital currencies. Coinbase stock, which has fallen sharply this year, rose 16% on Friday.",
    "url": "https://finnhub.io/api/news?id=6206b5d152dd0c16a00746d6eeef2dcbc00b16f5b7736738ae29729adc54e140",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771020753,
      "headline": "Stocks to Watch Friday Recap: Applied Materials, Coinbase, DraftKings",
      "id": 139091192,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "↗️ Coinbase (COIN): The largest U.S. cryptocurrency exchange swung to a loss in a quarter marked by a selloff in digital currencies. Coinbase stock, which has fallen sharply this year, rose 16% on Friday.",
      "url": "https://finnhub.io/api/news?id=6206b5d152dd0c16a00746d6eeef2dcbc00b16f5b7736738ae29729adc54e140"
    }
  },
  {
    "ts": null,
    "headline": "Equities Mixed After CPI Data; Wall Street Sees Worst Week Since November",
    "summary": "US equity benchmarks ended mixed on Friday as traders evaluated inflation data, capping Wall Street'",
    "url": "https://finnhub.io/api/news?id=0c48f56cffcd297adf2ff28dd8e64d7a8de1046aab3ddd2f1dce9575d9860295",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771019187,
      "headline": "Equities Mixed After CPI Data; Wall Street Sees Worst Week Since November",
      "id": 139089603,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "US equity benchmarks ended mixed on Friday as traders evaluated inflation data, capping Wall Street'",
      "url": "https://finnhub.io/api/news?id=0c48f56cffcd297adf2ff28dd8e64d7a8de1046aab3ddd2f1dce9575d9860295"
    }
  },
  {
    "ts": null,
    "headline": "Applied Materials, Rivian, Moderna, Arista, Fastly, Coinbase, Robinhood, DraftKings, and More Stock Market Movers",
    "summary": "Applied Materials shares surged after the semiconductor-equipment maker beat analysts’ quarterly earnings estimates.",
    "url": "https://finnhub.io/api/news?id=0f797222e21aa9aea2e639bc53b794a42dfdb95dad8b56a651f46998c2453632",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771017600,
      "headline": "Applied Materials, Rivian, Moderna, Arista, Fastly, Coinbase, Robinhood, DraftKings, and More Stock Market Movers",
      "id": 139091194,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Applied Materials shares surged after the semiconductor-equipment maker beat analysts’ quarterly earnings estimates.",
      "url": "https://finnhub.io/api/news?id=0f797222e21aa9aea2e639bc53b794a42dfdb95dad8b56a651f46998c2453632"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Inc. Q4 2025 Earnings Call Summary",
    "summary": "Moby summary of Moderna, Inc.'s Q4 2025 earnings call",
    "url": "https://finnhub.io/api/news?id=a768bfd94356e714b1b78309e0d91de34d556427749fa41c66c769761f19202f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771017341,
      "headline": "Moderna, Inc. Q4 2025 Earnings Call Summary",
      "id": 139089974,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moby summary of Moderna, Inc.'s Q4 2025 earnings call",
      "url": "https://finnhub.io/api/news?id=a768bfd94356e714b1b78309e0d91de34d556427749fa41c66c769761f19202f"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Dow, S&P 500, Nasdaq gains fizzle to cap week of sharp losses as AI fears grow",
    "summary": "Odds of a Fed rate cut in June nudge higher after 'core' consumer inflation comes in at its lowest rate in four years.",
    "url": "https://finnhub.io/api/news?id=8b394b80cd31671a4b56bb0e7330e5ccc690432a9cd611ca9ed655783590a609",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771016539,
      "headline": "Stock market today: Dow, S&P 500, Nasdaq gains fizzle to cap week of sharp losses as AI fears grow",
      "id": 139089685,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Odds of a Fed rate cut in June nudge higher after 'core' consumer inflation comes in at its lowest rate in four years.",
      "url": "https://finnhub.io/api/news?id=8b394b80cd31671a4b56bb0e7330e5ccc690432a9cd611ca9ed655783590a609"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Advance Late Afternoon",
    "summary": "Health care stocks rose late Friday afternoon, with the NYSE Health Care Index adding 0.7% and the S",
    "url": "https://finnhub.io/api/news?id=94fe6fd958b57dc5b98d8d9dbf8a43d4223f1d30f701e44c1fc430491acec995",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771015958,
      "headline": "Sector Update: Health Care Stocks Advance Late Afternoon",
      "id": 139089976,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Health care stocks rose late Friday afternoon, with the NYSE Health Care Index adding 0.7% and the S",
      "url": "https://finnhub.io/api/news?id=94fe6fd958b57dc5b98d8d9dbf8a43d4223f1d30f701e44c1fc430491acec995"
    }
  },
  {
    "ts": null,
    "headline": "Top S&P500 movers in Friday's session",
    "summary": "Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.",
    "url": "https://finnhub.io/api/news?id=e949128c1a554c67a72000917615d4af2652de36980c1eec7865a1bb6bba1f45",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771013110,
      "headline": "Top S&P500 movers in Friday's session",
      "id": 139088340,
      "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
      "related": "MRNA",
      "source": "ChartMill",
      "summary": "Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.",
      "url": "https://finnhub.io/api/news?id=e949128c1a554c67a72000917615d4af2652de36980c1eec7865a1bb6bba1f45"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Challenges FDA After Flu Shot Review Refusal, 26% Covid Drop",
    "summary": "Moderna Slams FDA After Flu Shot Review Rejection, 26% Covid Drop",
    "url": "https://finnhub.io/api/news?id=1a95850d837b51072e66ffe87eeca2a4f6ead3d3933a50067530f304fa9f437c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771010190,
      "headline": "Moderna Challenges FDA After Flu Shot Review Refusal, 26% Covid Drop",
      "id": 139087931,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna Slams FDA After Flu Shot Review Rejection, 26% Covid Drop",
      "url": "https://finnhub.io/api/news?id=1a95850d837b51072e66ffe87eeca2a4f6ead3d3933a50067530f304fa9f437c"
    }
  },
  {
    "ts": null,
    "headline": "Equities Rise Intraday as Markets Parse CPI Report",
    "summary": "US benchmark equity indexes were higher intraday as investors assessed the latest consumer inflation",
    "url": "https://finnhub.io/api/news?id=bfc895655470a594b9e413f505f505fa80d2caa665b51d0abd0d7de49a129331",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771009483,
      "headline": "Equities Rise Intraday as Markets Parse CPI Report",
      "id": 139087933,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes were higher intraday as investors assessed the latest consumer inflation",
      "url": "https://finnhub.io/api/news?id=bfc895655470a594b9e413f505f505fa80d2caa665b51d0abd0d7de49a129331"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Inc (MRNA) Q4 2025 Earnings Call Highlights: Strategic Cost Reductions Amidst Financial ...",
    "summary": "Despite a significant net loss, Moderna Inc (MRNA) showcases robust cost management and strategic international growth plans.",
    "url": "https://finnhub.io/api/news?id=df0000943ad8b0f46e04e23501a21b6555e71d7e471e91dc1a7695d7072544f4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771009265,
      "headline": "Moderna Inc (MRNA) Q4 2025 Earnings Call Highlights: Strategic Cost Reductions Amidst Financial ...",
      "id": 139087934,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Despite a significant net loss, Moderna Inc (MRNA) showcases robust cost management and strategic international growth plans.",
      "url": "https://finnhub.io/api/news?id=df0000943ad8b0f46e04e23501a21b6555e71d7e471e91dc1a7695d7072544f4"
    }
  },
  {
    "ts": null,
    "headline": "Friday's session: top gainers and losers in the S&P500 index",
    "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.",
    "url": "https://finnhub.io/api/news?id=a6d5fbb65e7b62b55258f7d99ecaac863967df635c2e772fcb62bacc5dbfaf72",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771004109,
      "headline": "Friday's session: top gainers and losers in the S&P500 index",
      "id": 139086377,
      "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
      "related": "MRNA",
      "source": "ChartMill",
      "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.",
      "url": "https://finnhub.io/api/news?id=a6d5fbb65e7b62b55258f7d99ecaac863967df635c2e772fcb62bacc5dbfaf72"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Roundup: Market Talk",
    "summary": "Find insight on Sanofi, Moderna and more in the latest Market Talks covering the health care sector.",
    "url": "https://finnhub.io/api/news?id=f54d0150006f9a62356756e90d9c94818e50d327eff8788910ef6160f49b0092",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771003620,
      "headline": "Health Care Roundup: Market Talk",
      "id": 139087935,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Find insight on Sanofi, Moderna and more in the latest Market Talks covering the health care sector.",
      "url": "https://finnhub.io/api/news?id=f54d0150006f9a62356756e90d9c94818e50d327eff8788910ef6160f49b0092"
    }
  },
  {
    "ts": null,
    "headline": "Moderna shares pop on strong guidance, smaller-than-expected loss",
    "summary": "Moderna Inc (NASDAQ:MRNA, XETRA:0QF) reported fourth quarter 2025 results that exceeded Wall Street expectations, sending its shares up about 11% on Friday. The company posted a net loss of $2.11 per share on revenue of $678 million, compared with analysts’ consensus of a $2.60 loss on...",
    "url": "https://finnhub.io/api/news?id=8ec372cf8fa4b32f986bc0cc2c858c5b03cc8b56c05f28d90f886b1446b6b665",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771002180,
      "headline": "Moderna shares pop on strong guidance, smaller-than-expected loss",
      "id": 139086838,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna Inc (NASDAQ:MRNA, XETRA:0QF) reported fourth quarter 2025 results that exceeded Wall Street expectations, sending its shares up about 11% on Friday. The company posted a net loss of $2.11 per share on revenue of $678 million, compared with analysts’ consensus of a $2.60 loss on...",
      "url": "https://finnhub.io/api/news?id=8ec372cf8fa4b32f986bc0cc2c858c5b03cc8b56c05f28d90f886b1446b6b665"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Q4 Loss Narrower-Than-Expected, Sales Beat Estimates",
    "summary": "MRNA posts a narrower Q4 loss and beats sales estimates, despite a 30% revenue drop, while advancing its pipeline and reaffirming 2026 outlook.",
    "url": "https://finnhub.io/api/news?id=04de3c58bb15a4e1acf0fe001236a6c7319e125fa53efd9e762ecc7f1397ee58",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771000680,
      "headline": "Moderna Q4 Loss Narrower-Than-Expected, Sales Beat Estimates",
      "id": 139086574,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "MRNA posts a narrower Q4 loss and beats sales estimates, despite a 30% revenue drop, while advancing its pipeline and reaffirming 2026 outlook.",
      "url": "https://finnhub.io/api/news?id=04de3c58bb15a4e1acf0fe001236a6c7319e125fa53efd9e762ecc7f1397ee58"
    }
  },
  {
    "ts": null,
    "headline": "Rivian stock surges on EV delivery outlook, Pinterest plunges",
    "summary": "Market Catalysts Host Julie Hyman tracks several of the day's top trending stock tickers, including shares of EV maker Rivian (RIVN) soaring, Pinterest stock (PINS) plunging over 20%, and Moderna (MRNA) topping fourth quarter revenue estimates. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finnhub.io/api/news?id=9ebcd867abf1fd7e4a33896dae3282553698bf6979ffadacd9c6114cfa87eea6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770997620,
      "headline": "Rivian stock surges on EV delivery outlook, Pinterest plunges",
      "id": 139085296,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Market Catalysts Host Julie Hyman tracks several of the day's top trending stock tickers, including shares of EV maker Rivian (RIVN) soaring, Pinterest stock (PINS) plunging over 20%, and Moderna (MRNA) topping fourth quarter revenue estimates. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
      "url": "https://finnhub.io/api/news?id=9ebcd867abf1fd7e4a33896dae3282553698bf6979ffadacd9c6114cfa87eea6"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Friday: Applied Materials, Rivian, Coinbase, DraftKings",
    "summary": "↗️ Coinbase Global (COIN): The largest U.S. cryptocurrency exchange swung to a loss in a quarter marked by a selloff in digital currencies. Coinbase stock, which has fallen sharply this year, rose 5.5% in premarket trading.",
    "url": "https://finnhub.io/api/news?id=db0cb75fedb0288b2b4e0bcad8df521245682c2e358480a8e82a340e7072d89a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770976710,
      "headline": "Stocks to Watch Friday: Applied Materials, Rivian, Coinbase, DraftKings",
      "id": 139079748,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "↗️ Coinbase Global (COIN): The largest U.S. cryptocurrency exchange swung to a loss in a quarter marked by a selloff in digital currencies. Coinbase stock, which has fallen sharply this year, rose 5.5% in premarket trading.",
      "url": "https://finnhub.io/api/news?id=db0cb75fedb0288b2b4e0bcad8df521245682c2e358480a8e82a340e7072d89a"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Q4 Earnings Call Highlights",
    "summary": "Moderna (NASDAQ:MRNA) executives highlighted progress on cost reductions, a ramp in international partnerships, and multiple late-stage pipeline milestones during the company’s fourth-quarter 2025 earnings call, while also addressing disappointment with a U.S. Food and Drug Administration refusal-to",
    "url": "https://finnhub.io/api/news?id=8288b63033441f740054b5009b77943d5554403c10466ab0a956ac2d503f566a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770996454,
      "headline": "Moderna Q4 Earnings Call Highlights",
      "id": 139085297,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (NASDAQ:MRNA) executives highlighted progress on cost reductions, a ramp in international partnerships, and multiple late-stage pipeline milestones during the company’s fourth-quarter 2025 earnings call, while also addressing disappointment with a U.S. Food and Drug Administration refusal-to",
      "url": "https://finnhub.io/api/news?id=8288b63033441f740054b5009b77943d5554403c10466ab0a956ac2d503f566a"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Maintains Full-Year Revenue Growth Outlook Following Fourth-Quarter Beat",
    "summary": "Moderna (MRNA) reiterated its full-year revenue growth outlook on Friday, while the drugmaker report",
    "url": "https://finnhub.io/api/news?id=e3ba7e8777b47bd78edf523ff7ee86a6421dc5ad8cc476fbb0c829be8f5b5eb3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770996370,
      "headline": "Moderna Maintains Full-Year Revenue Growth Outlook Following Fourth-Quarter Beat",
      "id": 139085298,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) reiterated its full-year revenue growth outlook on Friday, while the drugmaker report",
      "url": "https://finnhub.io/api/news?id=e3ba7e8777b47bd78edf523ff7ee86a6421dc5ad8cc476fbb0c829be8f5b5eb3"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Is Losing Less Money Than Expected. The Stock Jumps After Earnings.",
    "summary": "Shares of  Moderna  rose sharply Friday after the drugmaker reported better-than-expected quarterly results.  The company posted a fourth-quarter loss of $2.11 a share on revenue of $678 million.  Moderna  stock was up 7% after falling in premarket trading.",
    "url": "https://finnhub.io/api/news?id=9384d6ed255ad8292eddee710932b79895b4b4f61dd0da81fefa8b4554210495",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770995340,
      "headline": "Moderna Is Losing Less Money Than Expected. The Stock Jumps After Earnings.",
      "id": 139085299,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Shares of  Moderna  rose sharply Friday after the drugmaker reported better-than-expected quarterly results.  The company posted a fourth-quarter loss of $2.11 a share on revenue of $678 million.  Moderna  stock was up 7% after falling in premarket trading.",
      "url": "https://finnhub.io/api/news?id=9384d6ed255ad8292eddee710932b79895b4b4f61dd0da81fefa8b4554210495"
    }
  },
  {
    "ts": null,
    "headline": "Moderna (MRNA) Q4 2025 Earnings Call Transcript",
    "summary": "Lavina Talukdar: Thank you, Kevin.  Good morning, everyone, and thank you for joining us on today’s call to discuss Moderna, Inc.’s fourth quarter 2025 financial results and business update.  On today’s call are Stéphane Bancel, our Chief Executive Officer; Stephen Hoge, our President; and James Mock, our Chief Financial Officer.",
    "url": "https://finnhub.io/api/news?id=6cae591b640119711b9569a7e0747fe76c95b6828570c909366626cc8bb9857a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770993556,
      "headline": "Moderna (MRNA) Q4 2025 Earnings Call Transcript",
      "id": 139085300,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Lavina Talukdar: Thank you, Kevin.  Good morning, everyone, and thank you for joining us on today’s call to discuss Moderna, Inc.’s fourth quarter 2025 financial results and business update.  On today’s call are Stéphane Bancel, our Chief Executive Officer; Stephen Hoge, our President; and James Mock, our Chief Financial Officer.",
      "url": "https://finnhub.io/api/news?id=6cae591b640119711b9569a7e0747fe76c95b6828570c909366626cc8bb9857a"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Pops On Fourth-Quarter Report, But Can It Overcome Recent FDA Setbacks?",
    "summary": "Moderna stock popped Friday after the company reported better-than-expected fourth-quarter sales and reiterated its 2026 outlook.",
    "url": "https://finnhub.io/api/news?id=81d5c3f893c9ad74897b8826329e7b4dff77a4e93fe7d0ef1bc55bf52d448fa0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770991819,
      "headline": "Moderna Pops On Fourth-Quarter Report, But Can It Overcome Recent FDA Setbacks?",
      "id": 139085301,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna stock popped Friday after the company reported better-than-expected fourth-quarter sales and reiterated its 2026 outlook.",
      "url": "https://finnhub.io/api/news?id=81d5c3f893c9ad74897b8826329e7b4dff77a4e93fe7d0ef1bc55bf52d448fa0"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Reiterates 10% Revenue-Growth Target as Covid Vaccine Demand Falls",
    "summary": "Moderna reported falling fourth-quarter sales as Covid-19 vaccine demand continued to drop, but continues to target 10% revenue growth in 2026 following the launch of its next-generation Covid vaccine.",
    "url": "https://finnhub.io/api/news?id=359ac7e5b82c454d8ee88f8e78f8e6c90e5cfef97739c7dcc31b84a19ae27be0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770991380,
      "headline": "Moderna Reiterates 10% Revenue-Growth Target as Covid Vaccine Demand Falls",
      "id": 139085302,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna reported falling fourth-quarter sales as Covid-19 vaccine demand continued to drop, but continues to target 10% revenue growth in 2026 following the launch of its next-generation Covid vaccine.",
      "url": "https://finnhub.io/api/news?id=359ac7e5b82c454d8ee88f8e78f8e6c90e5cfef97739c7dcc31b84a19ae27be0"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Inc (NASDAQ:MRNA) Beats Q4 2025 Estimates Amid Post-Pandemic Transition",
    "summary": "Moderna beats Q4 2025 earnings and revenue estimates, navigating its post-pandemic transition with cost cuts and a focus on its pipeline.",
    "url": "https://finnhub.io/api/news?id=7903670cd233fae9c25132f96e5250ebab62a4081e6681da94fa7cad90cae9c1",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770988930,
      "headline": "Moderna Inc (NASDAQ:MRNA) Beats Q4 2025 Estimates Amid Post-Pandemic Transition",
      "id": 139080435,
      "image": "https://www.chartmill.com/images/uploads/earnings_article_1_defce97180.webp",
      "related": "MRNA",
      "source": "ChartMill",
      "summary": "Moderna beats Q4 2025 earnings and revenue estimates, navigating its post-pandemic transition with cost cuts and a focus on its pipeline.",
      "url": "https://finnhub.io/api/news?id=7903670cd233fae9c25132f96e5250ebab62a4081e6681da94fa7cad90cae9c1"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Just Crushed Estimates While Everyone Was Looking the Other Way",
    "summary": "Moderna (NASDAQ: MRNA) reported fourth-quarter results Friday morning that beat Wall Street’s muted expectations, delivering revenue of $678 million against estimates of $663 million and a loss of $2.11 per share compared to the expected loss of $2.64. The biotech’s shares had climbed 36% year-to-date through February 12 as investors anticipated signs of stabilization in ... Moderna Just Crushed Estimates While Everyone Was Looking the Other Way",
    "url": "https://finnhub.io/api/news?id=90c1aa04c054587eaa967a5509f68cc847353e75963ab15726e6189b01eaba07",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770988818,
      "headline": "Moderna Just Crushed Estimates While Everyone Was Looking the Other Way",
      "id": 139085303,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (NASDAQ: MRNA) reported fourth-quarter results Friday morning that beat Wall Street’s muted expectations, delivering revenue of $678 million against estimates of $663 million and a loss of $2.11 per share compared to the expected loss of $2.64. The biotech’s shares had climbed 36% year-to-date through February 12 as investors anticipated signs of stabilization in ... Moderna Just Crushed Estimates While Everyone Was Looking the Other Way",
      "url": "https://finnhub.io/api/news?id=90c1aa04c054587eaa967a5509f68cc847353e75963ab15726e6189b01eaba07"
    }
  },
  {
    "ts": null,
    "headline": "Moderna (MRNA) Reports Q4 Loss, Beats Revenue Estimates",
    "summary": "Moderna (MRNA) delivered earnings and revenue surprises of +18.75% and +2.81%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=16734f754ab176a616fff49d3c36eba6ed3c4760188740cd912b06b289bd5f06",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770988802,
      "headline": "Moderna (MRNA) Reports Q4 Loss, Beats Revenue Estimates",
      "id": 139085304,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) delivered earnings and revenue surprises of +18.75% and +2.81%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=16734f754ab176a616fff49d3c36eba6ed3c4760188740cd912b06b289bd5f06"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Narrows Loss, Reiterates 10% Revenue Growth Target",
    "summary": "Moderna said it continues to target 10% revenue growth this year, as the company’s fourth-quarter loss narrowed from a year earlier.",
    "url": "https://finnhub.io/api/news?id=4cac9c8811b15cca9892faaee68659130069c0b81979acdc73db9f1511cb5893",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770987360,
      "headline": "Moderna Narrows Loss, Reiterates 10% Revenue Growth Target",
      "id": 139081677,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna said it continues to target 10% revenue growth this year, as the company’s fourth-quarter loss narrowed from a year earlier.",
      "url": "https://finnhub.io/api/news?id=4cac9c8811b15cca9892faaee68659130069c0b81979acdc73db9f1511cb5893"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript",
    "summary": "Moderna, Inc. (MRNA) Q4 2025 Earnings Call February 13, 2026 8:00 AM ESTCompany ParticipantsLavina Talukdar - Senior VP & Head of Investor...",
    "url": "https://finnhub.io/api/news?id=7ecb26240b99d7b0352cd75508e235554e2dc162711815c9c8fe49ddf97a4bf7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770986869,
      "headline": "Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript",
      "id": 139086555,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Moderna, Inc. (MRNA) Q4 2025 Earnings Call February 13, 2026 8:00 AM ESTCompany ParticipantsLavina Talukdar - Senior VP & Head of Investor...",
      "url": "https://finnhub.io/api/news?id=7ecb26240b99d7b0352cd75508e235554e2dc162711815c9c8fe49ddf97a4bf7"
    }
  },
  {
    "ts": null,
    "headline": "Stocks making the biggest moves midday: Moderna, Instacart, Rivian Automotive, DraftKings, Coinbase & more",
    "summary": "Here are some of the biggest movers in midday trading.",
    "url": "https://finnhub.io/api/news?id=eecc84f88376a879caba590388a99eeee0c807fb6f8e4df6feabcb32937d19dc",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770986770,
      "headline": "Stocks making the biggest moves midday: Moderna, Instacart, Rivian Automotive, DraftKings, Coinbase & more",
      "id": 139086408,
      "image": "https://image.cnbcfm.com/api/v1/image/108179666-1753963608092-gettyimages-2219723511-s3___bgmp-arc_arc-feeds_generic-photos_to-arc_ryanmoderna4bi.jpeg?v=1771004067&w=1920&h=1080",
      "related": "MRNA",
      "source": "CNBC",
      "summary": "Here are some of the biggest movers in midday trading.",
      "url": "https://finnhub.io/api/news?id=eecc84f88376a879caba590388a99eeee0c807fb6f8e4df6feabcb32937d19dc"
    }
  },
  {
    "ts": null,
    "headline": "Moderna beats Q4 expectations, but stock edges lower on FDA setback",
    "summary": "Investing.com -- Moderna, Inc. (NASDAQ:MRNA) reported better-than-expected fourth quarter results on Thursday, though shares fell 0.8% with the company disclosing a regulatory setback for its influenza vaccine in the United States.",
    "url": "https://finnhub.io/api/news?id=09eaf477a057fe66fb612f9117efc1257a37ac366fcff405bd0ef4a29b129416",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770986561,
      "headline": "Moderna beats Q4 expectations, but stock edges lower on FDA setback",
      "id": 139081678,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Investing.com -- Moderna, Inc. (NASDAQ:MRNA) reported better-than-expected fourth quarter results on Thursday, though shares fell 0.8% with the company disclosing a regulatory setback for its influenza vaccine in the United States.",
      "url": "https://finnhub.io/api/news?id=09eaf477a057fe66fb612f9117efc1257a37ac366fcff405bd0ef4a29b129416"
    }
  },
  {
    "ts": null,
    "headline": "Moderna shares are trading higher after the company reported better-than-expected Q4 financial results.",
    "summary": "Moderna shares are trading higher after the company reported better-than-expected Q4 financial results.",
    "url": "https://finnhub.io/api/news?id=d7e8e0a56032518adfd6b875cc2a3ae03171227a05202173895693a303b66704",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770986247,
      "headline": "Moderna shares are trading higher after the company reported better-than-expected Q4 financial results.",
      "id": 139096170,
      "image": "",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=d7e8e0a56032518adfd6b875cc2a3ae03171227a05202173895693a303b66704"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Reports a Narrower-Than-Expected Loss. The Stock Slips After Earnings.",
    "summary": "Shares of  Moderna  slipped Friday after the drugmaker reported better-than-expected quarterly results.  The company posted a fourth-quarter loss of $2.11 a share on revenue of $678 million.  Moderna  stock was down 0.3% in premarket trading Friday.",
    "url": "https://finnhub.io/api/news?id=d3f746003bfaae326d0e8f9aaee9796fe65ce53863760d2a0a2330127286f19d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770985740,
      "headline": "Moderna Reports a Narrower-Than-Expected Loss. The Stock Slips After Earnings.",
      "id": 139081679,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Shares of  Moderna  slipped Friday after the drugmaker reported better-than-expected quarterly results.  The company posted a fourth-quarter loss of $2.11 a share on revenue of $678 million.  Moderna  stock was down 0.3% in premarket trading Friday.",
      "url": "https://finnhub.io/api/news?id=d3f746003bfaae326d0e8f9aaee9796fe65ce53863760d2a0a2330127286f19d"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Down Pre-Bell Ahead of Key Inflation Report",
    "summary": "The benchmark US stock measures were pointing lower before the open Friday as traders await a key in",
    "url": "https://finnhub.io/api/news?id=31befa5bfe23323d06f29cd96d9e5c765e43976ca8c30664eb18d7679d0e55bd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770985211,
      "headline": "Stocks Down Pre-Bell Ahead of Key Inflation Report",
      "id": 139081204,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The benchmark US stock measures were pointing lower before the open Friday as traders await a key in",
      "url": "https://finnhub.io/api/news?id=31befa5bfe23323d06f29cd96d9e5c765e43976ca8c30664eb18d7679d0e55bd"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: Q4 Earnings Snapshot",
    "summary": "CAMBRIDGE, Mass. AP) — Moderna Inc. MRNA) on Friday reported a loss of $826 million in its fourth quarter.",
    "url": "https://finnhub.io/api/news?id=f01ec55ebaf7fd452fd041d76487b2234f31defd01385e30930b79a4296eecfe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770984918,
      "headline": "Moderna: Q4 Earnings Snapshot",
      "id": 139081681,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, Mass. AP) — Moderna Inc. MRNA) on Friday reported a loss of $826 million in its fourth quarter.",
      "url": "https://finnhub.io/api/news?id=f01ec55ebaf7fd452fd041d76487b2234f31defd01385e30930b79a4296eecfe"
    }
  },
  {
    "ts": null,
    "headline": "Moderna beats quarterly revenue estimates on resilient sales of COVID shot",
    "summary": "Feb 13 () - Moderna reported fourth-quarter revenue above ‌Wall Street estimates on ‌Friday, banking on better-than-expected sales ​of its COVID-19 vaccine in the U. The Cambridge, Massachusetts-based company has been struggling ‌financially as ⁠demand for COVID vaccines collapsed in the ⁠years following its pandemic windfall.",
    "url": "https://finnhub.io/api/news?id=bb1cc14eb15d2d3c620cfc494594f762ca776a44fca3c7f82b77a9b01970d938",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770984741,
      "headline": "Moderna beats quarterly revenue estimates on resilient sales of COVID shot",
      "id": 139081682,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Feb 13 () - Moderna reported fourth-quarter revenue above ‌Wall Street estimates on ‌Friday, banking on better-than-expected sales ​of its COVID-19 vaccine in the U. The Cambridge, Massachusetts-based company has been struggling ‌financially as ⁠demand for COVID vaccines collapsed in the ⁠years following its pandemic windfall.",
      "url": "https://finnhub.io/api/news?id=bb1cc14eb15d2d3c620cfc494594f762ca776a44fca3c7f82b77a9b01970d938"
    }
  },
  {
    "ts": null,
    "headline": "Moderna (NASDAQ:MRNA) Exceeds Q4 CY2025 Expectations",
    "summary": "Biotechnology company Moderna (NASDAQ:MRNA) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 29.8% year on year to $678 million. Its GAAP loss of $2.11 per share was 18.9% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=4f8c20139d4582d331ae3f32cb4ede4136676b0edfa8c3e31e684bb14f3b1e0b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770984684,
      "headline": "Moderna (NASDAQ:MRNA) Exceeds Q4 CY2025 Expectations",
      "id": 139081683,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Biotechnology company Moderna (NASDAQ:MRNA) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 29.8% year on year to $678 million. Its GAAP loss of $2.11 per share was 18.9% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=4f8c20139d4582d331ae3f32cb4ede4136676b0edfa8c3e31e684bb14f3b1e0b"
    }
  },
  {
    "ts": null,
    "headline": "FDA Flu Setback Tests Moderna Valuation And Future mRNA Vaccine Pipeline",
    "summary": "U.S. FDA issues a Refusal to File for Moderna's mRNA flu vaccine BLA, citing concerns with the trial comparator rather than safety or efficacy. Moderna, ticker NasdaqGS:MRNA, says the trial design and comparator were agreed in advance with the FDA, raising questions about changing regulatory expectations. Reports of FDA leadership overruling internal expert staff have drawn attention to potential shifts in U.S. vaccine policy and oversight. For you as an investor, this sits at the core of...",
    "url": "https://finnhub.io/api/news?id=5789cf94454042055fbc4bb38865331df16ba6620077f3f8af318b5ae89a4808",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770984665,
      "headline": "FDA Flu Setback Tests Moderna Valuation And Future mRNA Vaccine Pipeline",
      "id": 139081684,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "U.S. FDA issues a Refusal to File for Moderna's mRNA flu vaccine BLA, citing concerns with the trial comparator rather than safety or efficacy. Moderna, ticker NasdaqGS:MRNA, says the trial design and comparator were agreed in advance with the FDA, raising questions about changing regulatory expectations. Reports of FDA leadership overruling internal expert staff have drawn attention to potential shifts in U.S. vaccine policy and oversight. For you as an investor, this sits at the core of...",
      "url": "https://finnhub.io/api/news?id=5789cf94454042055fbc4bb38865331df16ba6620077f3f8af318b5ae89a4808"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates",
    "summary": "Reports fourth quarter revenue of $0.7 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.11) Reports full-year revenue of $1.9 billion, GAAP net loss of $(2.8) billion and GAAP diluted EPS of $(7.26) Reiterates plan to deliver up to 10% ...",
    "url": "https://finnhub.io/api/news?id=faef3df42de1fc6a029a1722feb17fd4ee7365e8b5a7ea64c9bc6f525a291411",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770984000,
      "headline": "Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates",
      "id": 139079867,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Reports fourth quarter revenue of $0.7 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.11) Reports full-year revenue of $1.9 billion, GAAP net loss of $(2.8) billion and GAAP diluted EPS of $(7.26) Reiterates plan to deliver up to 10% ...",
      "url": "https://finnhub.io/api/news?id=faef3df42de1fc6a029a1722feb17fd4ee7365e8b5a7ea64c9bc6f525a291411"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Promises Revenue Growth In 2026, Even As FDA Flu Vaccine Setback Looms",
    "summary": "Moderna beat fourth-quarter sales expectations and forecast growth for 2026, but an FDA refusal on its flu vaccine raises new concerns.",
    "url": "https://finnhub.io/api/news?id=2f68be206abc223c838c3e8a51a4ba66c9c244b57dd8c71930e93e02489c2c27",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770983954,
      "headline": "Moderna Promises Revenue Growth In 2026, Even As FDA Flu Vaccine Setback Looms",
      "id": 139095502,
      "image": "https://cdn.benzinga.com/files/images/story/2026/02/13/Augsburg--Bavaria--Germany---March-21--2.jpeg?width=2048&height=1536",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "Moderna beat fourth-quarter sales expectations and forecast growth for 2026, but an FDA refusal on its flu vaccine raises new concerns.",
      "url": "https://finnhub.io/api/news?id=2f68be206abc223c838c3e8a51a4ba66c9c244b57dd8c71930e93e02489c2c27"
    }
  },
  {
    "ts": null,
    "headline": "Pharma and biotech are back, says UBS' Michael Yee",
    "summary": "Michael Yee, global head of biotech research at UBS, joins CNBC’s ‘Squawk on the Street’ to explain Moderna's narrower-than-expected loss, why healthcare is outperforming, and vaccine mandates and more.",
    "url": "https://finnhub.io/api/news?id=c8f2f0ff1adda77891cf0c403ae16084d63bcc59265497359eee35af4db88140",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770983796,
      "headline": "Pharma and biotech are back, says UBS' Michael Yee",
      "id": 139086082,
      "image": "https://image.cnbcfm.com/api/v1/image/108265632-17709986291770998624-44006177752-1080pnbcnews.jpg?v=1770998628&w=1920&h=1080",
      "related": "MRNA",
      "source": "CNBC",
      "summary": "Michael Yee, global head of biotech research at UBS, joins CNBC’s ‘Squawk on the Street’ to explain Moderna's narrower-than-expected loss, why healthcare is outperforming, and vaccine mandates and more.",
      "url": "https://finnhub.io/api/news?id=c8f2f0ff1adda77891cf0c403ae16084d63bcc59265497359eee35af4db88140"
    }
  },
  {
    "ts": null,
    "headline": "Apart From CPI Data, Here's What to Watch Friday",
    "summary": "This week has brought a deluge of economic indicators, with an inflation report that was stalled by the recent government closure still to come. Another shutdown may loom if Congress fails to reach a deal on immigration enforcement.",
    "url": "https://finnhub.io/api/news?id=89ddbb1f5bb87dbb1344e879bccf6c6261cf5a5f53272d2b33f1189d839f45e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770982280,
      "headline": "Apart From CPI Data, Here's What to Watch Friday",
      "id": 139081685,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "This week has brought a deluge of economic indicators, with an inflation report that was stalled by the recent government closure still to come. Another shutdown may loom if Congress fails to reach a deal on immigration enforcement.",
      "url": "https://finnhub.io/api/news?id=89ddbb1f5bb87dbb1344e879bccf6c6261cf5a5f53272d2b33f1189d839f45e4"
    }
  },
  {
    "ts": null,
    "headline": "Softer-Than-Expected Inflation Sparks Rally In These 10 Stocks",
    "summary": "U.S. inflation cooled to 2.4% in January, below expectations and the lowest since May 2025, boosting rate-cut hopes.",
    "url": "https://finnhub.io/api/news?id=01f5e4042122493ce46cf1c368b70050b8d8d0137272fdcf290fe68ffc208acb",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770980513,
      "headline": "Softer-Than-Expected Inflation Sparks Rally In These 10 Stocks",
      "id": 139095454,
      "image": "https://cdn.benzinga.com/files/images/story/2026/02/13/Representative-Image-of-a-stock-market-r.jpeg?width=2048&height=1536",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "U.S. inflation cooled to 2.4% in January, below expectations and the lowest since May 2025, boosting rate-cut hopes.",
      "url": "https://finnhub.io/api/news?id=01f5e4042122493ce46cf1c368b70050b8d8d0137272fdcf290fe68ffc208acb"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Today’s Movers: Applied Materials, Arista, Coinbase, DraftKings, Expedia, Rivian, Roku, Pinterest, and More",
    "summary": "Applied Materials shares surge after the semiconductor-equipment maker beats analysts’ quarterly earnings estimates.",
    "url": "https://finnhub.io/api/news?id=af1502ca1abbe6dbc4f1ed396e486c4a2a4550e775282047630cd3bcd7fb626a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770980040,
      "headline": "These Stocks Are Today’s Movers: Applied Materials, Arista, Coinbase, DraftKings, Expedia, Rivian, Roku, Pinterest, and More",
      "id": 139079832,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Applied Materials shares surge after the semiconductor-equipment maker beats analysts’ quarterly earnings estimates.",
      "url": "https://finnhub.io/api/news?id=af1502ca1abbe6dbc4f1ed396e486c4a2a4550e775282047630cd3bcd7fb626a"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Exec Says Co Is \"Hoping For\" Approval Of The Flu-covid Combination Vaccine In Europe This Year; Awaits Us Guidance On Flu Vaccine To Refile Application For COVID-flu Combination Vaccine",
    "summary": "-Reuters",
    "url": "https://finnhub.io/api/news?id=e0e6c7f5bf63ad48407e705d3378d080e66c2b49f73989463c9b171d2b5d435f",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770975834,
      "headline": "Moderna Exec Says Co Is \"Hoping For\" Approval Of The Flu-covid Combination Vaccine In Europe This Year; Awaits Us Guidance On Flu Vaccine To Refile Application For COVID-flu Combination Vaccine",
      "id": 139081072,
      "image": "",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "-Reuters ",
      "url": "https://finnhub.io/api/news?id=e0e6c7f5bf63ad48407e705d3378d080e66c2b49f73989463c9b171d2b5d435f"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation",
    "summary": "2026-02-13. The following slide deck was published by Moderna, Inc.",
    "url": "https://finnhub.io/api/news?id=64574710892452057b768d9f9aeab9097e8bc8fe450effcb164743ef583b76ce",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770971496,
      "headline": "Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation",
      "id": 139080477,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "2026-02-13. The following slide deck was published by Moderna, Inc.",
      "url": "https://finnhub.io/api/news?id=64574710892452057b768d9f9aeab9097e8bc8fe450effcb164743ef583b76ce"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Is Targeting Up To 10% Growth From 2025 Revenue And Expects 2026 Revenue Split To Be ~50% U.S. And ~50% International",
    "summary": "2026 Financial FrameworkCost of Sales: Cost of sales for 2026 is expected to be approximately $0.9 billion.Research and Development Expenses: Research and development expenses for 2026 are anticipated to be approximately",
    "url": "https://finnhub.io/api/news?id=dd434aa51a92dda8fa51d10c4a0241c35b7c0da8147455e23197a1bbd2835171",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770969853,
      "headline": "Moderna Is Targeting Up To 10% Growth From 2025 Revenue And Expects 2026 Revenue Split To Be ~50% U.S. And ~50% International",
      "id": 139081073,
      "image": "",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "2026 Financial FrameworkCost of Sales: Cost of sales for 2026 is expected to be approximately $0.9 billion.Research and Development Expenses: Research and development expenses for 2026 are anticipated to be approximately",
      "url": "https://finnhub.io/api/news?id=dd434aa51a92dda8fa51d10c4a0241c35b7c0da8147455e23197a1bbd2835171"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Q4 Earnings Summary & Key Takeaways",
    "summary": "",
    "url": "https://finnhub.io/api/news?id=6480a3029b9f0276a7ce5091de34ee1169908944a3b02c0593c0a4950e459746",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770969728,
      "headline": "Moderna Q4 Earnings Summary & Key Takeaways",
      "id": 139081074,
      "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/analyst_ratings_4.jpg?width=2048&height=1536",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": " ",
      "url": "https://finnhub.io/api/news?id=6480a3029b9f0276a7ce5091de34ee1169908944a3b02c0593c0a4950e459746"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Q4 EPS $(2.11) Beats $(2.59) Estimate, Sales $678.000M Beat $626.097M Estimate",
    "summary": "Moderna Q4 EPS $(2.11) Beats $(2.59) Estimate, Sales $678.000M Beat $626.097M Estimate",
    "url": "https://finnhub.io/api/news?id=bbd47dadc05ed54883f83a7ed8797eef9df553e2705e34088ebf6f312613cf7e",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770969686,
      "headline": "Moderna Q4 EPS $(2.11) Beats $(2.59) Estimate, Sales $678.000M Beat $626.097M Estimate",
      "id": 139081075,
      "image": "",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=bbd47dadc05ed54883f83a7ed8797eef9df553e2705e34088ebf6f312613cf7e"
    }
  },
  {
    "ts": null,
    "headline": "Earnings Scheduled For February 13, 2026",
    "summary": "",
    "url": "https://finnhub.io/api/news?id=5e6acb3e5baec092ab64bc4aba0816348e82cd777a87c77d89cfb42933df9f06",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770966669,
      "headline": "Earnings Scheduled For February 13, 2026",
      "id": 139080546,
      "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/earnings_scheduled_1.jpg?width=2048&height=1536",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": " ",
      "url": "https://finnhub.io/api/news?id=5e6acb3e5baec092ab64bc4aba0816348e82cd777a87c77d89cfb42933df9f06"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts",
    "summary": "",
    "url": "https://finnhub.io/api/news?id=22b5b2f963ebd5542fa2021aa2e969e5d26b9cf952bcb01d7b4eb5b4360665f7",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770952437,
      "headline": "Moderna Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts",
      "id": 139081077,
      "image": "https://cdn.benzinga.com/files/images/story/2026/02/13/Two-Vials-Of-The-Moderna-Vaccine-With-A-.jpeg?width=2048&height=1536",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": " ",
      "url": "https://finnhub.io/api/news?id=22b5b2f963ebd5542fa2021aa2e969e5d26b9cf952bcb01d7b4eb5b4360665f7"
    }
  },
  {
    "ts": null,
    "headline": "Review & Preview: Another Rally Lost",
    "summary": "REVIEW PREVIEW NEWSLETTER Here We Go Again. The market keeps serving up head fakes. After starting the day on a positive note once again, all three indexes ended the day in the red. The Dow Jones Industrial Average fell 669 points, or 1.",
    "url": "https://finnhub.io/api/news?id=98314a0260410e9a21dcf4b96e5c7d1aa355bdfd3284c92383e351f377a3dcb1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770944100,
      "headline": "Review & Preview: Another Rally Lost",
      "id": 139077156,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "REVIEW PREVIEW NEWSLETTER Here We Go Again. The market keeps serving up head fakes. After starting the day on a positive note once again, all three indexes ended the day in the red. The Dow Jones Industrial Average fell 669 points, or 1.",
      "url": "https://finnhub.io/api/news?id=98314a0260410e9a21dcf4b96e5c7d1aa355bdfd3284c92383e351f377a3dcb1"
    }
  },
  {
    "ts": null,
    "headline": "January CPI, Moderna and Wendy's earnings: What to Watch",
    "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Friday, February 13, including the latest inflation data being released in the form of January's Consumer Price Index (CPI) and earnings results from companies like Moderna (MRNA), Wendy's (WEN), and Advance Auto Parts (AAP). To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.",
    "url": "https://finnhub.io/api/news?id=fdb359047f61644b792fbc550c9777675a4824f69cc6cc9512b92311813e7509",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770940815,
      "headline": "January CPI, Moderna and Wendy's earnings: What to Watch",
      "id": 139076305,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Friday, February 13, including the latest inflation data being released in the form of January's Consumer Price Index (CPI) and earnings results from companies like Moderna (MRNA), Wendy's (WEN), and Advance Auto Parts (AAP). To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.",
      "url": "https://finnhub.io/api/news?id=fdb359047f61644b792fbc550c9777675a4824f69cc6cc9512b92311813e7509"
    }
  }
]